MONTARA
Live / Applied — Third extension granted (statement of use) (as of 27 Jan 2026)
What this means for you
Not registered yet, but its 31 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98159331
- Mark type
- Stylized text
- Filed
- 31 Aug 2023
- Published for opposition
- 04 Jun 2024
- Attorney of record
- Michael R. Graif
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for treating neurological conditions and diseases
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological conditions and diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Montara Therapeutics, Inc., San Francisco, CA, US
- Montara Therapeutics, Inc., San Francisco, CA, US
Prosecution history
- 28 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2026 — SOU EXTENSION 3 GRANTED
- 27 Jan 2026 — SOU EXTENSION 3 FILED
- 27 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Aug 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 01 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2025 — SOU EXTENSION 2 GRANTED
- 17 Jun 2025 — SOU EXTENSION 2 FILED
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED